A reported 24% fall in Cameco stock is not, by itself, a reason to sell or buy. The figure and its exact measurement window are not verified by the company disclosures available here, and those filings do not establish what caused a subsequent share-price move. Cameco’s latest reported results are mixed: management raised its 2026 revenue and realized-uranium-price outlook, but lower Westinghouse earnings pulled down year-over-year consolidated results. Whether CCJ or CCO is attractive now depends on the share price and valuation, your view of uranium contracts and operating execution, and how much volatility your portfolio can bear.
Is the reported 24% decline verified?
Not by Cameco’s Q2 2026 release, quarterly report or July 2026 management discussion and analysis. Those documents report company performance and outlook, not a three-month daily share-price series. They do not establish the start and end dates, listing, currency or adjusted-versus-unadjusted price convention behind the headline figure. Treat 24% as a reported move unless you confirm it against dated market data for the relevant listing: Cameco trades as CCO on the TSX and CCJ on the NYSE.
Those details matter: a percentage return can differ depending on whether it is measured in Canadian or US dollars, which closing dates are selected, and whether dividends are included. The company’s July disclosures also cannot establish why a later stock decline occurred.
What Cameco’s latest results say—and what they do not
Cameco’s Q2 2026 results, released July 31, show a weaker year-over-year consolidated comparison, driven primarily by lower equity earnings from Westinghouse. The uranium business also posted lower Q2 earnings and adjusted EBITDA than a year earlier, which the company attributed to normal delivery variation and lower planned 2026 sales deliveries. These figures are relevant to the business outlook, but they do not explain or prove the cause of a later share-price move.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →| Issuer-reported measure | Q2 2026 | First half of 2026 |
|---|---|---|
| Net earnings | C$25 million | C$156 million |
| Adjusted net earnings | C$77 million | C$281 million |
| Adjusted EBITDA | C$391 million | C$899 million |
Adjusted net earnings and adjusted EBITDA are non-IFRS measures. In the uranium segment, Q2 earnings before taxes were C$170 million, compared with C$281 million in Q2 2025; adjusted EBITDA was C$252 million, compared with C$352 million. Cameco reported improving average realized prices from market-related contracts, but quarterly delivery volumes and sales plans also affected the comparison. Cameco’s Q2 2026 results release provides the reported figures and management’s explanation.
What could support Cameco’s outlook?
Management said long-term uranium prices strengthened in the first half of 2026 and contracting activity increased as customers placed more emphasis on security of supply. That is Cameco’s characterization of market conditions, not an independent uranium-market price series. The company reported contracts for average annual deliveries exceeding 28 million pounds over the next five years, with commitments above average in 2026–28 and below average in 2029–30. Cameco said it expected to add further volumes using market-related pricing. The contracts offer a base of planned deliveries, but sales prices, purchases and timing still matter to realized results. The Q2 release and Q2 report describe the company’s market commentary and delivery commitments.
2026 outlook updated in July
Management raised its 2026 revenue and average realized uranium-price outlook while holding its production guidance. These are forward-looking ranges, not guaranteed outcomes.
| 2026 outlook measure | Company range or assumption |
|---|---|
| Consolidated revenue | C$3.32–3.57 billion |
| Uranium revenue | C$2.70–2.91 billion |
| Average realized uranium price | C$91–96 per pound |
| Uranium average unit cost of sales | C$63–67.50 per pound |
| Uranium production attributable to Cameco | 19.5–21.5 million pounds |
The revenue, realized-price and unit-cost ranges come from Cameco’s July 2026 MD&A; production guidance is from the Q2 report. Management said the outlook depends on sourcing and delivering required material and achieving production plans, and used a US$1.35-to-C$1 exchange-rate assumption for the remainder of 2026. Read the ranges with those conditions in mind rather than treating them as a forecast of earnings per share or stock return. The Q2 2026 MD&A sets out the revenue, price, cost and currency assumptions; the Q2 report gives production guidance.
Rank #3
- Comes with secure packaging
- Easy to read text
- It can be a gift option
Why production and sourcing still matter
Cameco reported Q2 uranium deliveries of 7.1 million pounds. In the same quarter, attributable production was 3.9 million pounds, and the company purchased 2.8 million pounds at an average C$91.40 per pound (US$66.60). At June 30, inventory stood at 8.7 million pounds, with an average cost of C$58.05 per pound. These are quarterly and point-in-time figures; they do not, on their own, establish future margins. If Cameco must buy material to meet deliveries, purchase prices and the terms of its customer contracts can affect the economics.
Management maintained 2026 production guidance despite temporary disruptions at Key Lake and McArthur River and later at Cigar Lake, as well as challenging spring road conditions along northern Saskatchewan supply routes. That is the outlook as of the July report, not assurance that later mine, mill, transport, labor or sourcing performance will match plan. Cameco’s Q2 report details production, purchases, deliveries and inventory.
Rank #4
How much does Westinghouse change the investment case?
Westinghouse contributed to the weaker consolidated comparison. Cameco reported a C$10 million net loss attributable to it in Q2 2026, versus C$126 million in earnings in Q2 2025; Cameco said the earlier quarter included a contribution from the Dukovany project. Cameco’s share of Westinghouse adjusted EBITDA was C$163 million in Q2 2026, compared with C$352 million a year earlier. This sharp comparison makes it important to separate the uranium business from Westinghouse when interpreting quarterly totals.
Westinghouse could also add potential growth, but reactor-project expectations involve timing and execution risk. Cameco’s 2025 annual-report outlook for Westinghouse depended on definitive agreements and US government funding or support for reactor deployments. Those conditions are not the same as secured, recurring earnings. The Q2 release reports the quarterly results; Cameco’s 2025 annual report describes the outlook assumptions.
Best Value
Does the balance sheet make the stock safe?
At June 30, 2026, Cameco reported C$1.1 billion in cash, C$1.0 billion in total debt and a C$1.0 billion undrawn revolving credit facility. Those figures describe liquidity and debt at that date. They do not establish that the stock is attractively valued or remove exposure to commodity prices, operating disruptions, project timing or foreign-exchange movements. The Q2 release reports the balance-sheet figures.
Buy, hold or sell: a practical decision framework
The available company disclosures do not provide a current fair value, price target, analyst consensus or peer valuation. A recent drop alone cannot fill those gaps. Compare the three choices using the same share-price date, currency, assumptions and investment horizon.
- Consider buying only if: your own valuation work suggests the current price offers an acceptable return even if uranium prices, production or Westinghouse projects disappoint. Test the effect of contract pricing and purchase commitments rather than assuming spot uranium prices flow immediately into Cameco’s results.
- Consider holding if: your original thesis still fits the company’s contract position and operating outlook, and the position remains appropriate for your portfolio despite the possibility of volatility. Reassess if the production, sourcing or project assumptions behind your thesis change.
- Consider selling or reducing if: the investment no longer fits your risk tolerance, time horizon, liquidity needs or diversification plan, or if a disciplined valuation using your assumptions no longer supports holding it. Selling because the share price fell, without checking those factors, is not an analysis of the business.
For any of those choices, examine normalized earnings or cash flow, the contract portfolio and the lag between market conditions and realized prices, production and sourcing risks, Westinghouse’s contribution and project timing, currency exposure, and your position size. The 2025 annual report discusses how Cameco’s contracts and purchase terms affect uranium-price sensitivity. Its amounts are generally in Canadian dollars, while US-listed CCJ trades in US dollars; exchange rates can therefore affect a US investor’s reported return. The annual report provides the company’s discussion of contract and purchase-term exposure.
Quick Recap
What to verify before acting
- Check the alleged three-month return using the exact exchange, start and end dates, currency, and price-return or total-return method that matter to you.
- Use the latest share price and financial statements to calculate a valuation measure you can compare consistently with Cameco’s normalized earnings or cash flow. The company disclosures cited here do not supply a current fair value.
- Stress-test your assumptions for realized uranium prices, purchase costs, production delivery, exchange rates and Westinghouse project timing; distinguish management guidance from results already reported.
- Decide what portfolio weight and potential loss you can tolerate before placing or changing an order.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitches
